Aarhus University Seal / Aarhus Universitets segl

Sussie Antonsen

β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. / Lemeshow, Stanley; Sørensen, Henrik Toft; Phillips, Gary; Yang, Eric V; Antonsen, Sussie; Riis, Anders H; Lesinski, Gregory B; Jackson, Rebecca; Glaser, Ronald.

In: Cancer Epidemiology, Biomarkers & Prevention, Vol. 20, No. 10, 2011, p. 2273-9.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

Lemeshow, S, Sørensen, HT, Phillips, G, Yang, EV, Antonsen, S, Riis, AH, Lesinski, GB, Jackson, R & Glaser, R 2011, 'β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study', Cancer Epidemiology, Biomarkers & Prevention, vol. 20, no. 10, pp. 2273-9. https://doi.org/10.1158/1055-9965.EPI-11-0249

APA

Lemeshow, S., Sørensen, H. T., Phillips, G., Yang, E. V., Antonsen, S., Riis, A. H., Lesinski, G. B., Jackson, R., & Glaser, R. (2011). β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiology, Biomarkers & Prevention, 20(10), 2273-9. https://doi.org/10.1158/1055-9965.EPI-11-0249

CBE

Lemeshow S, Sørensen HT, Phillips G, Yang EV, Antonsen S, Riis AH, Lesinski GB, Jackson R, Glaser R. 2011. β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiology, Biomarkers & Prevention. 20(10):2273-9. https://doi.org/10.1158/1055-9965.EPI-11-0249

MLA

Vancouver

Author

Lemeshow, Stanley ; Sørensen, Henrik Toft ; Phillips, Gary ; Yang, Eric V ; Antonsen, Sussie ; Riis, Anders H ; Lesinski, Gregory B ; Jackson, Rebecca ; Glaser, Ronald. / β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. In: Cancer Epidemiology, Biomarkers & Prevention. 2011 ; Vol. 20, No. 10. pp. 2273-9.

Bibtex

@article{95519fae2e234371a6a1eddb545d9ed6,
title = "β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study",
abstract = "To study whether use of β-blockers increases survival in patients with malignant melanoma because experimental data suggest that catecholamine hormones may be involved in stimulating the aggressiveness of malignant melanoma.",
author = "Stanley Lemeshow and S{\o}rensen, {Henrik Toft} and Gary Phillips and Yang, {Eric V} and Sussie Antonsen and Riis, {Anders H} and Lesinski, {Gregory B} and Rebecca Jackson and Ronald Glaser",
note = "{\textcopyright}2011 AACR",
year = "2011",
doi = "10.1158/1055-9965.EPI-11-0249",
language = "English",
volume = "20",
pages = "2273--9",
journal = "Cancer Epidemiology, Biomarkers & Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research (A A C R)",
number = "10",

}

RIS

TY - JOUR

T1 - β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study

AU - Lemeshow, Stanley

AU - Sørensen, Henrik Toft

AU - Phillips, Gary

AU - Yang, Eric V

AU - Antonsen, Sussie

AU - Riis, Anders H

AU - Lesinski, Gregory B

AU - Jackson, Rebecca

AU - Glaser, Ronald

N1 - ©2011 AACR

PY - 2011

Y1 - 2011

N2 - To study whether use of β-blockers increases survival in patients with malignant melanoma because experimental data suggest that catecholamine hormones may be involved in stimulating the aggressiveness of malignant melanoma.

AB - To study whether use of β-blockers increases survival in patients with malignant melanoma because experimental data suggest that catecholamine hormones may be involved in stimulating the aggressiveness of malignant melanoma.

U2 - 10.1158/1055-9965.EPI-11-0249

DO - 10.1158/1055-9965.EPI-11-0249

M3 - Journal article

C2 - 21933972

VL - 20

SP - 2273

EP - 2279

JO - Cancer Epidemiology, Biomarkers & Prevention

JF - Cancer Epidemiology, Biomarkers & Prevention

SN - 1055-9965

IS - 10

ER -